Global Industry Analysts, a leading publisher of market research, has released a new research report titled, “Laboratory Automation: A Global Outlook”. According to the report, the global laboratory automation industry will reach US$4.1 billion by 2015.
The emerging need of biotechnology and pharmaceutical companies to accelerate the process of drug discovery is driving opportunities in the worldwide laboratory automation market.
The report offers a set of market briefs, statistical anecdotes, and brief summaries of research findings. It provides statistical insights, highlights new trends and developments and offers an overview about the industry. The report covers regional markets such as Europe, US, Asia, Africa and Brazil. It compiles new product launches, acquisitions, mergers, and corporate developments. It also features an indexed, fact-finder directory that lists the contact details of companies across the globe.
Lab automation minimizes the requirement for time-consuming procedures by substituting them with innovative tools and techniques that reduce expenditures and boost efficiencies. In fact, laboratory automation systems are used in a number of lab processes. Pharmaceutical companies face increasing pressure to develop new and effective drugs and the time-to-market is also an important aspect. These factors highlight the importance of automated laboratories. Lab automation increases the speed and precision of tests, allowing sufficient time for scientists to focus on important activities.
Lab automation is also attracting the interest of automation product producers who view it as a suitable opportunity to reinforce their presence. Pharmaceutical, biotechnology, clinical research and Contract Research Organizations sectors are the main markets for lab automation.
Source: http://www.strategyr.com/